I Just Bought This M&A King With My 2020 TFSA Contribution

Alimentation Couche-Tard Inc. (TSX:ATD.B) is an M&A king that became a must-buy stock on the coronavirus pullback.

Golden crown on a red velvet background

Image source: Getty Images

Alimentation Couche-Tard (TSX:ATD.B) is one of few Canadian firms that has perfected the growth-by-acquisition model. The convenience store kingpin is fortunate enough to be in a fragmented niche market. But for M&A-oriented firms, that’s only half the battle. It’s Couche’s stellar management team that allows the company to create value in the form of synergies from every deal that it makes.

M&A is no guarantee of value creation

As you may know, acquirers must pay substantial premiums to an acquiree’s public market value, making it tough for any acquirer to produce real value via M&A activities alone in the long run. That’s why the stock of an acquirer tends to go down on the announcement of an acquisition.

Due diligence is key to creating “1 + 1 = 3”-type synergies from acquisitions. The price paid ought to account for integration risks, integration effort, and all the sort.

A “1 + 1 = 3” scenario is no guarantee after making an acquisition. And if an acquirer overpays or overestimates synergies to be had, the acquisition under question may not make sense, as shareholder value could stand to be destroyed.

A firm with a Berkshire Hathaway-like approach to M&A

I like to view Couche as a Berkshire Hathaway of the convenience store industry.

Like Berkshire, Couche isn’t interested in acquiring anything if the price isn’t right or if there’s no chance at realizing sufficient synergies given the risks. Couche’s prudence and patience has allowed it to maintain its impressive growth rate while maintaining impressive return on invested capital numbers.

Couche CEO Brian Hannasch and his team are ridiculously patient. They’ll keep busy through organic growth initiatives if the opportunities to pay three quarters to get a dollar via M&A don’t exist. The amount of due diligence that Hannasch and company put in prior to pulling the trigger is quite admirable.

Sometimes walking away is the best course of action

Couche recently walked away from its pursuit of Caltex Australia amid the coronavirus pandemic. The company put in a ridiculous amount of due diligence into a potential Caltex deal, so it may have been disheartening for investors to hear Couche dropped its US$5.6 billion bid.

Caltex was seen by many as a missing piece to the puzzle and would have given Couche a foundation to grow in the Australasian market. However, I’m a huge fan of Couche’s decision to shelve the Caltex Australia buyout, which has been in the works for months.

Why? Caltex had its fair share of issues well before the coronavirus hit. Now that the risks have been raised substantially because of the coronavirus and the fact that liquidity has suddenly become worth its weight in gold, the “sweetened” deal to buy Caltex, I thought, no longer made sense for Couche. With a recession looming, Couche can get a much better bang for its buck by waiting it out.

Foolish takeaway

Over the coming months, Caltex is really going to start to feel the pressure. Meanwhile, many alternative opportunities could open up in the c-store market that could allow Couche to pay less to get more, all thanks to its enviable liquidity position.

Who knows? Caltex may be more than willing to take some sweetener out of the original deal now that Couche has taken a walk amid this coronavirus crisis.

In any case, I’m a raging bull on Couche, with its impressive liquidity position that’ll allow it to scoop up bargains as they come along over the painful coming months. If you’ve got room in your TFSA, you may want to consider nibbling away on the dip, too!

Stay hungry. Stay Foolish.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Joey Frenette owns shares of ALIMENTATION COUCHE-TARD INC and Berkshire Hathaway (B shares). The Motley Fool owns shares of and recommends Berkshire Hathaway (B shares). The Motley Fool recommends ALIMENTATION COUCHE-TARD INC and recommends the following options: long January 2021 $200 calls on Berkshire Hathaway (B shares), short January 2021 $200 puts on Berkshire Hathaway (B shares), and short June 2020 $205 calls on Berkshire Hathaway (B shares).

More on Coronavirus

healthcare pharma

TSX Stocks in the Healthcare Industry: Which Ones Are Worth Your Money?

These healthcare stocks all offer different investment opportunities for investors, but which are the best buys on the TSX today?

Read more »

Man considering whether to sell or buy

Air Canada Stock is Down 16% – Time to Buy?

Air Canada stock has sure taken its bruises. Will recovering demand this year and next be enough to offset rapidly…

Read more »

little girl in pilot costume playing and dreaming of flying over the sky

Air Canada Stock: How High Could it go?

AC stock is up 29% in the last six months alone, so should we expect more great things? Or is…

Read more »

eat food

Goodfood Stock Doubles Within Days: Time to Buy?

Goodfood (TSX:FOOD) stock has surged 125% in the last few weeks, so what happened, and should investors hop back on…

Read more »

stock data
Tech Stocks

If I Could Only Buy 1 Stock Before 2023, This Would Be It

This stock is the one company that really doesn't deserve its ultra-low share price, so I'll definitely pick it up…

Read more »

Aircraft Mechanic checking jet engine of the airplane

Air Canada Stock Fell 5% in November: Is it a Buy Today?

Air Canada (TSX:AC) stock saw remarkable improvements during its last quarter but still dropped 5% with more recession hints. So,…

Read more »

Airport and plane

Is Air Canada Stock a Buy Today?

Airlines are on the rebound. Does Air Canada stock deserve to be on your buy list?

Read more »

A patient takes medicine out of a daily pill box.

Retirees: 2 Healthcare Stocks That Could Help Set You up for Life

Healthcare stocks offer an incredible opportunity for growth for those investors who look to the right stocks, such as these…

Read more »